Treatment with the combination of AZD6738, an inhibitor of ATR, and olaparib significantly improved ionizing radiation-induced resistance, suggesting that combination therapy with two or more agents might be an effective approach for treating cancers intrinsically resistant to radiation.529. This evidence concerns the gene ATR and cancer.